Inflammation contributes to the elevation of the CA 19-9 value, and it can be assessed by monitoring the acute-phase proteins; one of these is the C-reactive protein (CRP), which rises in response to infection, injury and neoplasms [36,37,38]. This evidence concerns the gene CRP and neoplasm.